Amylyx Pharmaceuticals (AMLX) Other Non Operating Income (2021 - 2026)
Amylyx Pharmaceuticals (AMLX) posted Other Non Operating Income of -$53,000 for Q2 2026, compared with -$546,000 a year earlier.
Powered by 
Analysis
Amylyx Pharmaceuticals (AMLX) Other Non Operating Income (2021 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Other Non Operating Income at Amylyx Pharmaceuticals was $54,000; for FY2025, it was -$700,000.
- In prior years, Amylyx Pharmaceuticals' Other Non Operating Income was -$1.21 million in FY2024, -$660,000 in FY2023, -$551,000 in FY2022 and -$51,000 in FY2021.
- Quarterly Other Non Operating Income has run from a low of -$747,000 in Q1 2024 to a high of $362,000 in Q4 2025 over five years.
- According to Business Quant data, Other Non Operating Income for the three prior quarters was -$75,000 (Q1 2026), $362,000 (Q4 2025) and -$180,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Amylyx Pharmaceuticals | 3.13 Bn | 3.13 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -53,000.00 |
| Mar 31, 2026 | -75,000.00 |
| Dec 31, 2025 | 362,000.00 |
| Sep 30, 2025 | -180,000.00 |
| Jun 30, 2025 | -546,000.00 |
| Mar 31, 2025 | -335,000.00 |
| Dec 31, 2024 | 157,000.00 |
| Sep 30, 2024 | -141,000.00 |
| Jun 30, 2024 | -483,000.00 |
| Mar 31, 2024 | -747,000.00 |
| Dec 31, 2023 | 171,000.00 |
| Sep 30, 2023 | -488,000.00 |
| Jun 30, 2023 | -81,000.00 |
| Mar 31, 2023 | -262,000.00 |
| Dec 31, 2022 | -689,000.00 |
| Sep 30, 2022 | 199,000.00 |
| Jun 30, 2022 | -42,000.00 |
| Mar 31, 2022 | -19,000.00 |
| Dec 31, 2021 | -59,000.00 |
| Sep 30, 2021 | -227,000.00 |
API Access
Amylyx Pharmaceuticals Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=AMLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "AMLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=AMLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();